Meenhard Herlyn

Meenhard Herlyn's AcademicInfluence.com Rankings

Meenhard Herlyn

Philosophy

#5573

World Rank

#8412

Historical Rank

Logic

#2830

World Rank

#3889

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Meenhard Herlyn's Degrees

Doctorate Medicine University of Hamburg

Why Is Meenhard Herlyn Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Meenhard Herlyn's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Colorectal carcinoma antigens detected by hybridoma antibodies (1979) (1355)
Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. (1990) (768)
Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. (1979) (668)
Specific antigen in serum of patients with colon carcinoma. (1981) (594)
N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. (2001) (493)
Gastrointestinal cancer-associated antigen in immunoperoxidase assay. (1982) (440)
Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. (2003) (437)
Suppression of BRAF(V599E) in human melanoma abrogates transformation. (2003) (417)
E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. (2000) (350)
Study of antibodies against human melanoma produced by somatic cell hybrids. (1978) (345)
Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. (1983) (317)
Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies. (1984) (301)
Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine. (1994) (298)
Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. (1989) (284)
Characteristics of cultured human melanocytes isolated from different stages of tumor progression. (1985) (283)
Cyclin D1 is a candidate oncogene in cutaneous melanoma. (2002) (281)
Biology of tumor progression in human melanocytes. (1987) (258)
Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. (1980) (255)
Shifts in cadherin profiles between human normal melanocytes and melanomas. (1996) (254)
Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. (1993) (242)
Regulation of extracellular matrix proteins and integrin cell substratum adhesion receptors on epithelium during cutaneous human wound healing in vivo. (1993) (232)
Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. (1998) (229)
Human melanoma progression in skin reconstructs : biological significance of bFGF. (2000) (228)
Cytogenetics of human malignant melanoma and premalignant lesions. (1984) (225)
Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. (1991) (214)
Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosome 7 in malignant melanoma (1985) (209)
Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development (2001) (205)
CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations (2009) (204)
Melanoma development and progression: a conspiracy between tumor and host. (2002) (203)
Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. (1999) (203)
Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2. (2013) (202)
Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. (1999) (191)
Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. (1991) (190)
Chromatin binding of epidermal growth factor, nerve growth factor, and platelet-derived growth factor in cells bearing the appropriate surface receptors. (1986) (188)
Function and regulation of melanoma–stromal fibroblast interactions: when seeds meet soil (2003) (187)
Karyotypic evolution in human malignant melanoma. (1986) (184)
Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. (2000) (183)
Melanoma cells and normal melanocytes share antigens recognized by HLA- A2-restricted cytotoxic T cell clones from melanoma patients (1993) (181)
Absence of BRAF mutations in UV-protected mucosal melanomas (2004) (180)
Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects. (1987) (172)
The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. (1995) (167)
Differential response of primary and metastatic melanomas to neutrophils attracted by IL‐8 (2003) (166)
Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide. (1987) (163)
Molecular events in melanoma development and progression. (1998) (158)
Mouse monoclonal antibodies against human cancer cell lines with specificities for blood group and related antigens. Characterization by antibody binding to glycosphingolipids in a chromatogram binding assay. (1983) (155)
Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. (1985) (150)
Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factor (PDGF) and produce a PDGF-like growth factor. (1986) (150)
Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. (1993) (149)
Isolation and functional characterization of the A32 melanoma-associated antigen. (1994) (148)
Monoclonal antibodies in cell‐mediated cytotoxicity against human melanoma and colorectal carcinoma (1979) (148)
Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells. (1980) (142)
Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions. (1996) (142)
Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. (1989) (137)
Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. (1994) (135)
Adenoviral mediated gene transfer of PDGF‐B enhances wound healing in type I and type II diabetic wounds (2004) (134)
Monoclonal antibodies directed against the sugar sequence of lacto-N-fucopentaose III are obtained from mice immunized with human tumors. (1982) (130)
Dynamics of intercellular communication during melanoma development. (2000) (129)
Radioimmunodetection of human tumor xenografts by monoclonal antibodies. (1983) (127)
Adenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischemic impaired wound healing. (1999) (126)
Differentiation of normal skin and melanoma using high resolution hyperspectral imaging (2006) (125)
Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. (1993) (125)
Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes (1999) (124)
Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. (1999) (124)
Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation. (1992) (122)
Progression-related expression of beta3 integrin in melanomas and nevi. (1999) (122)
Interleukin-8 Overexpression Is Present in Pyoderma Gangrenosum Ulcers and Leads to Ulcer Formation in Human Skin Xenografts (2000) (121)
Melanoma antigens: immunological and biological characterization and clinical significance. (1988) (119)
Proton NMR and fast-atom bombardment mass spectrometry analysis of the melanoma-associated ganglioside 9-O-acetyl-GD3. (1985) (118)
Undifferentiated keratinocytes control growth, morphology, and antigen expression of normal melanocytes through cell-cell contact. (1993) (116)
Monoclonal antibody localization of Lewis antigens in fixed tissue. (1984) (114)
Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression. (1995) (113)
Growth-regulatory factors for normal, premalignant, and malignant human cells in vitro. (1990) (112)
Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ligand adhesion. (1997) (111)
Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells. (2000) (111)
Efficient selection of human tumor growth-inhibiting monoclonal antibodies. (1984) (110)
Integrin Distribution in Malignant Melanoma : Association of the ÃŸ 3 Subunit with Tumor Progression 1 (2006) (108)
Identification of melanoma-associated antigens using fixed tissue screening of antibodies. (1984) (106)
The cell-cell adhesion receptor Mel-CAM acts as a tumor suppressor in breast carcinoma. (1997) (105)
Regulatory factors that determine growth and phenotype of normal human melanocytes. (1988) (105)
Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors. (2001) (105)
Human/severe combined immunodeficient mouse chimeras. An experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules. (1993) (103)
Permissive environment in postnatal wounds induced by adenoviral‐mediated overexpression of the anti‐inflammatory cytokine interleukin‐10 prevents scar formation (2008) (103)
Mutation and expression of the p53 gene in malignant melanoma cell lines (1993) (103)
Melanoma Chondroitin Sulfate Proteoglycan Regulates Matrix Metalloproteinase-dependent Human Melanoma Invasion into Type I Collagen* (2001) (103)
T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2- restricted and melanocyte-lineage-specific CTL clone (1993) (101)
UVB induces atypical melanocytic lesions and melanoma in human skin. (1998) (100)
A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue. (1998) (99)
Human melanoblasts in culture: expression of BRN2 and synergistic regulation by fibroblast growth factor-2, stem cell factor, and endothelin-3. (2003) (98)
Lessons from melanocyte development for understanding the biological events in naevus and melanoma formation (2000) (98)
Cellular and Molecular Biology of Human Melanoma (2002) (96)
Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways. (2001) (93)
p73beta, unlike p53, suppresses growth and induces apoptosis of human papillomavirus E6-expressing cancer cells. (1998) (92)
Malignant melanoma simulants arising in congenital melanocytic nevi do not show experimental evidence for a malignant phenotype. (1990) (92)
Expression of melanoma-associated antigens in rapidly dividing human melanocytes in culture. (1987) (92)
Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway (2011) (91)
Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels (2007) (90)
MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines (2014) (89)
Dynamics of cell interactions and communications during melanoma development. (2002) (88)
Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides. (1989) (88)
Inhibition of human tumor growth by IgG2A monoclonal antibodies correlates with antibody density on tumor cells. (1985) (88)
HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes. (1984) (88)
Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin. (2001) (87)
Reciprocal regulation of MelCAM and AKT in human melanoma (2003) (86)
Monoclonal antibody localization of A and B isoantigens in normal and malignant fixed human tissues. (1984) (86)
The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium. (2008) (86)
FGF2-Targeted adenovirus encoding platelet-derived growth factor-B enhances de novo tissue formation. (2000) (85)
Induction of Melanoma Phenotypes in Human Skin by Growth Factors and Ultraviolet B (2004) (85)
Functional erythropoietin autocrine loop in melanoma. (2005) (84)
Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells. (1985) (83)
Characterization of chromosome 1 abnormalities in malignant melanomas (2000) (83)
Biologic and therapeutic significance of MYB expression in human melanoma. (1994) (82)
Role of growth factors and their receptors in the development and progression of melanoma. (1993) (82)
Regulatory pathways in tumor growth and invasion. (1991) (80)
GD2 ganglioside biosynthesis is a distinct biochemical event in human melanoma tumor progression (1986) (79)
Oncogenic BRAF regulates β-Trcp expression and NF-κB activity in human melanoma cells (2007) (79)
Bone morphogenetic proteins in melanoma: Angel or devil? (2005) (78)
CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma. (2015) (78)
Reactivity of monoclonal anti‐melanoma antibodies with melanoma cells freshly isolated from primary and metastatic melanoma (1979) (76)
Autocrine and paracrine roles for growth factors in melanoma. (1994) (75)
Release of monoclonal antibody-defined antigens by human colorectal carcinoma and melanoma cells. (1981) (73)
Clinical Protocol: Phase I trial to evaluate the safety of H5.020CMV.PDGF‐B for the treatment of a diabetic insensate foot ulcer (2000) (72)
Production and characterization of monoclonal antibodies against human malignant melanoma. (1983) (72)
Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity. (1987) (71)
Melanoma: The Wistar Melanoma (WM) Cell Lines (2002) (70)
Monoclonal antibody to a highly glycosylated protein reacts in fixed tissue with melanoma and other tumors. (1985) (70)
Volatile biomarkers from human melanoma cells. (2013) (70)
Presence of tumor-associated antigens in epidermal growth factor receptors from different human carcinomas. (1987) (68)
Human skin reconstruct models: a new application for studies of melanocyte and melanoma biology. (2001) (68)
Isolation and chemical characterization of a melanoma-associated proteoglycan antigen. (1983) (68)
Characterization of tenascin secreted by human melanoma cells. (1991) (68)
Phenotypes and interactions of human melanocytes and keratinocytes in an epidermal reconstruction model. (1990) (67)
Serum CEA and CA 19‐9: Potential future diagnostic or screening tests for gallbladder cancer? (1990) (67)
Monoclonal anti-human tumor antibodies of six isotypes in cytotoxic reactions with human and murine effector cells. (1985) (64)
Downregulation of CCN3 expression as a potential mechanism for melanoma progression (2008) (63)
Lewis blood group antigens defined by monoclonal anti-colon carcinoma antibodies. (1984) (61)
Development of invasive and growth factor-independent cell variants from primary human melanomas. (1991) (61)
Characterization of Lewis antigens in normal colon and gastrointestinal adenocarcinomas. (1985) (60)
Adhesion receptors in human melanoma progression. (1994) (59)
Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes. (1987) (59)
Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors. (1982) (59)
Interactions of melanocytes and melanoma cells with the microenvironment. (1994) (58)
Activated ras. Yet another player in melanoma? (1996) (57)
Epidermal integrin expression is upregulated rapidly in human fetal wound repair. (1998) (57)
Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells. (2007) (56)
Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor‐derived EGF/TGF‐α (1990) (56)
CO 17-1A and related monoclonal antibodies: their production and characterization. (1986) (55)
Growth and phenotypic characteristics of human nevus cells in culture. (1988) (55)
Monocyte chemoattractant protein‐1 (MCP‐1) inhibits the intestinal‐like differentiation of monocytes (2006) (54)
Basic fibroblast growth factor in human melanoma. (1991) (54)
AKT induces senescence in primary esophageal epithelial cells but is permissive for differentiation as revealed in organotypic culture (2007) (54)
Expression of DR antigens in freshly frozen human tumors. (1982) (54)
Nerve growth factor receptors in chromatin of melanoma cells, proliferating melanocytes, and colorectal carcinoma cells in vitro. (1988) (53)
Protein kinases in normal and transformed melanocytes (1994) (52)
Structural alteration in the MYB protooncogene and deletion within the gene encoding alpha-type protein kinase C in human melanoma cell lines. (1988) (52)
Genetic and antigenic heterogeneity of different parapoxvirus strains. (1980) (52)
A slow-cycling subpopulation of melanoma cells with highly invasive properties (2017) (52)
Differential expression of protein kinase C and cAMP-dependent protein kinase in normal human melanocytes and malignant melanomas. (1990) (52)
Stroma formation and angiogenesis by overexpression of growth factors, cytokines, and proteolytic enzymes in human skin grafted to SCID mice. (2003) (51)
A t(1;19) chromosome translocation in three cases of human malignant melanoma. (1986) (50)
Rapid apoptosis in the pulmonary vasculature distinguishes non-metastatic from metastatic melanoma cells. (2004) (49)
Cisplatin down-regulation of cellular Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory proteins to restore tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human melanoma cells. (2003) (48)
Nerve growth and expression of receptors for nerve growth factor in tumors of melanocyte origin. (1991) (48)
Characterization of gastrointestinal tumor-associated carcinoembryonic antigen-related antigens defined by monoclonal antibodies. (1984) (48)
All-trans retinoic acid (atRA) differentially induces apoptosis in matched primary and metastatic melanoma cells -- a speculation on damage effect of atRA via mitochondrial dysfunction and cell cycle redistribution. (2003) (47)
The putative tumor suppressor BIN1 is a short-lived nuclear phosphoprotein, the localization of which is altered in malignant cells. (1997) (46)
Periostin cooperates with mutant p53 to mediate invasion through the induction of STAT1 signaling in the esophageal tumor microenvironment (2013) (46)
In Vitro Growth Patterns of Normal Human Melanocytes and Melanocytes from Different Stages of Melanoma Progression (1992) (45)
Detection of carcinoembryonic antigen and related antigens in sera of patients with gastrointestinal tumors using monoclonal antibodies in double-determinant radioimmunoassays. (1983) (44)
Protein tyrosine phosphatase genes downregulated in melanoma. (2001) (43)
Carcinogenesis in human skin grafted to SCID mice. (1996) (43)
Phenotypic characteristics of cells derived from precursors of human melanoma. (1983) (42)
p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma (2002) (41)
Development of pemphigus vulgaris-like lesions in severe combined immunodeficiency disease mice reconstituted with lymphocytes from patients. (1993) (41)
Novel and known protein tyrosine kinases and their abnormal expression in human melanoma. (1993) (40)
Mitogenic activity of laminin on human melanoma and melanocytes: different signal requirements and role of beta 1 integrins. (1995) (40)
Multiparameter evaluation of the expression in situ of normal and tumor-associated antigens in human colorectal carcinoma. (1986) (38)
Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells (2004) (38)
Structure, function, and clinical significance of human tumor antigens. (1990) (38)
Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma. (1987) (37)
Naïve adult stem cells from patients with Hutchinson-Gilford progeria syndrome express low levels of progerin in vivo (2012) (37)
Ex vivo perfusion of a tumor-containing colon with monoclonal antibody. (1981) (35)
Quantitative dot blot analyses of blood‐group‐related antigens in paired normal and malignant human breast tissues (1992) (35)
The expression of colorectal carcinoma-associated antigens in the normal colonic mucosa. An immunohistochemical analysis of regional distribution. (1989) (35)
Immunoassay for melanoma-associated proteoglycan in the sera of patients using monoclonal and polyclonal antibodies. (1984) (35)
Shedding of human tumor-associated antigens in vitro and in vivo. (1987) (35)
Human Xenografts, Human Skin and Skin Reconstructs for Studies in Melanoma Development and Progression (2004) (34)
Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model. (2000) (34)
Tumor progression in the human melanocytic system. (1989) (34)
Distinct patterns of DNA copy number alterations associate with BRAF mutations in melanomas and melanoma‐derived cell lines (2009) (33)
No longer a molecular black box--new clues to apoptosis and drug resistance in melanoma. (2001) (33)
Ex vivo perfusion of human colon with monoclonal anticolorectal cancer antibodies (1982) (33)
Induction of p21 WAF1/CIP1 and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16 INK4a (1999) (31)
Growth regulation of cultured human nevus cells. (1993) (31)
An antimelanoma monoclonal antibody and the histopathology of uveal melanomas. (1985) (30)
Clinical protocol. Phase I trial to evaluate the safety of H5.020CMV.PDGF-b and limb compression bandage for the treatment of venous leg ulcer: trial A. (2004) (29)
Flow cytometric determination of the frequency and heterogeneity of expression of human melanoma-associated antigens. (1989) (29)
Selection of monoclonal antibodies detecting serodiagnostic human tumor markers. (1985) (28)
Detection of a circulating gastrointestinal cancer antigen in sera of patients with gastrointestinal malignancies by a double determinant immunoassay with monoclonal antibodies against human blood group determinants. (1984) (28)
Increased levels of circulating HLA-DR antigen in sera of patients with acute lymphoblastoid leukemia. (1984) (28)
Microarray analysis of phosphatase gene expression in human melanoma (2005) (26)
Hsu M, Andl T, Li G, Meinkoth JL, Herlyn MCadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J Cell Sci 113: 1535-1542 (2000) (25)
Human antibody induction to the idiotypic and anti-idiotypic determinants of a monoclonal antibody against a gastrointestinal carcinoma antigen. (1985) (25)
Expression of colorectal carcinoma-associated antigens in colonic polyps. (1993) (24)
UVB induction of epithelial tumors in human skin using a RAG-1 mouse xenograft model. (1997) (24)
Production and Characterization of Monoclonal Antibodies to Peripheral and Central Nervous System Myelin (1984) (24)
Interactions between growth factor receptors and corresponding monoclonal antibodies in human tumors (1987) (23)
Expression and structure of human SPARC transcripts: SPARC mRNA is expressed by human cells involved in extracellular matrix production and some of these cells show an unusual expression pattern. (1990) (23)
A simple procedure for determining Lewis phenotypes in human saliva. (1983) (22)
Overexpression of IL-8 in the cornea induces ulcer formation in the SCID mouse (2006) (22)
Raf inhibitor stabilizes receptor for the type I interferon but inhibits its anti-proliferative effects in human malignant melanoma cells (2007) (22)
An antisense strategy for inhibition of human melanoma growth targets the growth factor pleiotrophin. (2000) (22)
Tissue distribution and biochemical properties of an ocular melanoma-associated antigen. (1985) (21)
Spontaneous and induced differentiation of human melanoma cells (1993) (21)
Mechanisms of tumor growth inhibition. (1986) (20)
Increased sensitivity in detecting tumor-associated antigens in sera of patients with colorectal carcinoma. (1984) (20)
Pathophysiology of tumor progression in human gallbladder: flow cytometry, CEA, and CA 19-9 levels in bile and serum in different stages of gallbladder disease. (1989) (20)
Human allogeneic melanoma‐reactive T‐helper lymphocyte clones: Functional analysis of lymphocyte‐melanoma interactions (1991) (18)
A new organotypic model to study cell interactions in the intestinal mucosa (2006) (18)
A versatile method for the removal of melanin from ribonucleic acids in melanocytic cells (2002) (18)
Cytotoxicity of the matrix metalloproteinase–activated anthrax lethal toxin is dependent on gelatinase expression and B-RAF status in human melanoma cells (2008) (18)
Lewis and related tumor-associated determinants on ovarian carcinoma. (1987) (18)
Transformation of normal human melanocytes and non‐malignant nevus cells by adenovirus 12‐SV40 hybrid virus (1989) (18)
Expression of integrin alpha10 is induced in malignant melanoma. (2006) (18)
Comparative study of the binding characteristics of monoclonal antimelanoma antibodies. (1982) (18)
Melanoma biology and progression. (2001) (17)
Placental gene transfer: transgene screening in mice for trophic effects on the placenta. (2009) (17)
A mucin containing the X, Y, and H type 2 carbohydrate determinants is shed by carcinoma cells. (1987) (16)
Cultivation of normal human epidermal melanocytes. (1996) (15)
Cytokine modulation of antigen expression in human melanoma cell lines derived from primary and metastatic tumour tissues (1997) (15)
Regulation of growth and phenotype of normal human melanocytes in culture. (1991) (15)
Cyclin D 1 Is a Candidate Oncogene in Cutaneous Melanoma 1 (2002) (15)
Immunophenotyping of compound and spitz nevi and vertical growth-phase melanomas using a panel of monoclonal antibodies reactive in paraffin sections. (1993) (15)
Cellular pathways leading to melanoma differentiation: therapeutic implications (1994) (15)
The Nerve Growth Factor Receptor in Normal and Transformed Neural Crest Cells a (1986) (14)
Circulating tumor markers and assessment or response to intrahepatic chemotherapy of colon carcinoma (1985) (14)
The administration schedule of cyclin-dependent kinase inhibitor gene therapy and etoposide chemotherapy is a major determinant of cytotoxicity. (1999) (14)
Nesbit M, Nesbit HK, Bennett J, Andl T, Hsu MY, Dejesus E, McBrian M, Gupta AR, Eck SL, Herlyn MBasic fibroblast growth factor induces a transformed phenotype in normal human melanocytes. Oncogene 18: 6469-6476 (1999) (14)
Common antigenic sites on exfoliated cells derived from cervical carcinoma and in tumor cells of nonuterine origin as demonstrated by monoclonal antibodies in immunoperoxidase assay. (1985) (14)
Radioimmunodetection of human tumor xenografts by monoclonal antibody F(ab')2 fragments. (1986) (14)
Thrombospondin Receptor (CD36) Expression of Human Keratinocytes during Wound Healing in a SCID Mouse/Human Skin Repair Model (1996) (13)
Growth‐factor‐independence and invasive properties of colorectal carcinoma cells (1992) (13)
Repopulation of Langerhans cells during wound healing in an experimental human skin/SCID mouse model. (1996) (13)
[Stability in drinking and surface water of nine virus species from different genera (author's transl)]. (1977) (13)
Tumor progression in melanoma: the biology of epidermal melanocytes in vitro. (1989) (13)
Expression of Integrin Alpha10 Is Induced in Malignant Melanoma (2007) (13)
Development of monoclonal antibodies that recognize antigens associated with human cervical carcinoma. (1986) (12)
Suppression of BRAFV 599 E in Human Melanoma Abrogates Transformation 1 (2003) (12)
Metastatic uveal melanoma: an ocular melanoma associated antigen in the serum of patients with metastatic disease. (1986) (11)
Experimental model of human melanoma metastases. (1991) (11)
Studies of mammalian ornithine decarboxylase using a monoclonal antibody. (1984) (10)
Identification and isolation of Lewis blood group antigens from human saliva using monoclonal antibodies. (1984) (10)
[Control of ecthyma contagiosum (pustular dermatitis) of sheep with a new parenteral cell culture live vaccine]. (1981) (10)
Epitope- and antigen-specific cancer vaccines. (1991) (9)
Ultraviolet B–induced squamous epithelial and melanocytic cell changes in a xenograft model of cancer development in human skin (1998) (9)
Adenovirus infection enhances killing of melanoma cells by a mitotoxin. (1997) (9)
Human milk fat globule membrane glycoproteins express blood group-related determinants primarily on mucin-like epithelial membrane antigens and gp70. (1990) (8)
Antigens in ocular and cutaneous melanomas. (1983) (8)
Adenovirus-Mediated Ex Vivo Gene Transfer of Human Vascular Endothelial Growth Factor in a Rabbit Laryngotracheal Reconstruction Model (2002) (8)
α5 and α2 Integrin Gene Transfers Mimic the PDGF-B–Induced Transformed Phenotype of Fibroblasts in Human Skin (2001) (8)
Expression of PKC isoforms in human melanocytic cells in situ. (2006) (7)
Transforming growth factor-alpha secretion by epidermal growth factor-dependent human tumor cell lines. (1990) (7)
Experimental induction of human atypical melanocytic lesions and melanoma in ultraviolet-irradiated human skin grafted to immunodeficient mice. (2001) (6)
Differential diagnosis between mesotheliomas and metastatic adenocarcinomas using monoclonal antibodies against gastrointestinal carcinoma antigen and stage-specific embryonic antigen. (1986) (5)
Monoclonal antibodies to melanoma-associated antigens, hybridomas that produce these antibodies, and their use. (1988) (5)
Characteristics of cultured human melanocytes from different stages of tumor progression. (1988) (5)
Irish society of gastroenterology (1992) (5)
Placental Gene Transfer: Transgene Screening in Mice for Trophic Effects on the Placenta (2011) (5)
Stable Transfection of Human Malignant Melanoma Cells with Basic Fibroblast Growth Factor Antisense cDNA a (1992) (5)
Vascular Endothelial Growth Factor Is a Marker of Tumor Invasion and Metastasis in Squamous Cell Carcinomas of the Head and Neck 1 (1999) (4)
The prevalence of interferon-alpha transcription defects in malignant melanoma (2005) (4)
Alpha5 and alpha2 integrin gene transfers mimic the PDGF-B-induced transformed phenotype of fibroblasts in human skin. (2001) (4)
Antigens associated with tumor progression in melanocytic neoplasia. (2008) (4)
Rapid dissociation of adherent human tumor cells by ultrasound. (1987) (4)
Advances in Brief Constitutive Mitogen-activated Protein Kinase Activation in Melanoma Is Mediated by Both BRAF Mutations and Autocrine Growth Factor Stimulation 1 (2003) (4)
[Comparative studies on the demonstration and formation of serum antibodies against the Borna virus]. (1978) (4)
Detection of murine immunoglobulin in human tissues following therapeutic infusion of monoclonal antibody. (1986) (4)
CD20-immunotargeting of malignant melanoma. (2010) (3)
Effector Cells in ADCC with Anti-Breast Cancer Monoclonal Antibodies (1985) (3)
Immunodiagnosis of Human Solid Tumours (1984) (3)
The human melanocyte system as a model for studies on tumor progression. (1991) (3)
Cellular immunity and the immunotherapy of cancer (2007) (2)
[Growth factors in the pathogenesis of malignant diseases]. (2008) (2)
Association of polymorphisms of FAS-1377, FAS-670, and FASL-844 genes with risk factors for cutaneous malignant melanoma. (2007) (2)
Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. I. Role of HLA-DR antigens as stimulatory molecules. (1985) (2)
Biology of melanocytes and melanoma in human skin reconstructs (2000) (2)
[Peroral immunization against pox. 5. Effectiveness of drinking water vaccination against fowl pox]. (2010) (2)
In vitro skin reconstructs to study cell-cell and cell-matrix interactions in human melanoma (1998) (2)
Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles (2012) (1)
Stimulation of phagocytic activity by dextran. (1972) (1)
Abstract 1239: CDKN2B loss promotes progression from benign melanocytic nevus to melanoma (2015) (1)
Evaluation of monoclonal antibody to 19-9 antigen as a potential screening technique for colorectal cancer in a high-risk population. (1984) (1)
Human tumor antigens (1985) (1)
Isolation and analysis of novel human melanocyte-specific cDNA clones. (1994) (0)
Ovarian Surface Epithelium The Differential Role of L 1 in Ovarian Carcinoma and Normal (2008) (0)
Growth factors with autocrine and paracrine functions in melanoma progression and invasion: 72 (1993) (0)
Insulin-like Growth Factor-1 Induces Survival and Growth of Biologically Early Melanoma Cells through Both the Mitogen-activated Protein Kinase and (cid:1) -Catenin Pathways 1 (2001) (0)
Advances in Brief Induction of Melanoma Phenotypes in Human Skin by Growth Factors and Ultraviolet (2004) (0)
Metastatic but not primary melanoma cells escape from neutrophil attack induced by adenoviral gene transfer of interleukin-8 (1998) (0)
T Cell Receptor (TCR) Structure of Autologous Melanoma-reactive Cytotoxic T Lymphocyte (CTL) Clones: Tumor-lnfiltrating Lymphocytes Overexpress In Vivo the TCR f3 Chain Sequence Used by an HLA-A2-restricted and Melanocyte-lineage-specific (2003) (0)
Dynamics of Cell Adhesion Interactions during Melanoma Development (2005) (0)
The Basement Membrane in Benign and Malignant Melanocytic Lesions1 (1992) (0)
Mechanisms of hepatocyte growth factor induced regulation of cell adhesion in melanocytic cells (2007) (0)
044 Adenoviral Gene Transfer of IL‐10 Differentially Regulates Hyaluronic Acid Synthase 1: Implications for Scarless Wound Healing (2004) (0)
Patents and literature (1985) (0)
Melanoma: Mutations in Multiple Pathways at the Tumor-Stroma Interface (2010) (0)
Irish Society of Gastroenterology (1993) (0)
[Stability of Teschen, HCC, ND and vaccinia viruses against 5 disinfectants]. (1976) (0)
Identificationof Melanoma-associatedAntigensUsingFixedTissue Screeningof Antibodies1 (2006) (0)
Monoclonal antibodies and immobilized antibodies (1987) (0)
Gene expression of RNA for b3 integrin and CD9 in malignant melanoma and melanocytic nevi, evaluated by cDNA expression array profiling (1999) (0)
Fifteenth Sir Peter Freyer Memorial Lecture and Surgical Symposium Proceedings of meeting held 14th & 15th September, 1990 at University College, Galway (1991) (0)
Irish association for cancer research (1991) (0)
Nerve Growth Factor Receptors in Chromatin of Melanoma Cells , Proliferating Melanocytes , and Colorectal Carcinoma Cells in Vitro 1 (2006) (0)
Monoclonal antibodies allow differentiation between carcinoma dysplasia hyperplasia and cholecystitis in human gallbladder sections (1986) (0)
Differences in antigen expression between neoplastic and nonneoplastic gallbladder epithelium (2005) (0)
A 19-9 monoclonal antibody study of adenocarcinoma metastatic to the choroid. (1984) (0)
Dynamicsof Celli Nteractions Andc Ommunications Duringmelanomadevelopment (0)
Sixteenth sir peter freyer memorial lecture and surgical symposium September 13th & 14th, 1991 Session I (1992) (0)
Recognition of lineage-specific antigens on melanoma and melanocytes by HLA-A2-restricted cytolytic T cell clones: 75 (1993) (0)
Monoclonal antibodies against antigens associated with melanoma, hybrid cell lines producing these antibodies, and their corresponding employment. (1988) (0)
153 Utility of adenoviruses as gene expression vectors in melanocytic cells (1997) (0)
Royal Academy of Medicine in Ireland Section of Sugery (1989) (0)
[Interview with Dr. M. Herlyn, Philadelphia. The new magic formula: monoclonal antibodies]. (1983) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Meenhard Herlyn?

Meenhard Herlyn is affiliated with the following schools:

University of Pennsylvania